Literature DB >> 30081407

Ultrasonography Classification of the American Thyroid Association for Predicting Malignancy in Thyroid Nodules >1cm with Indeterminate Cytology: A Prospective Study.

Tiara Grossi Rocha1, Pedro Weslley Rosario1, Alexandre Lemos Silva1, Maurício Buzelin Nunes1, Tulio Henrique Silva2, Pedro Henrique Lopes de Oliveira2, Maria Regina Calsolari1.   

Abstract

The objective of this prospective study was to evaluate the ultrasonography classification of the American Thyroid Association (ATA) for predicting malignancy in thyroid nodules >1 cm with indication for fine-needle aspiration (FNA) whose cytology was indeterminate. Additionally, the combination of the ATA classification with Doppler analysis was evaluated. All patients with thyroid nodules >1 cm were eligible. Each nodule was assigned to one of the ATA categories. Exclusively or predominantly intranodular vascularity was considered suspicious. One hundred and thirty-seven patients with 143 nodules underwent FNA and those with indeterminate cytology (Bethesda category III or IV) were selected. All patients were referred for surgery. Among the 143 nodules evaluated, 92 were benign, 33 were malignant, 13 were noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP), and 5 were tumors of uncertain malignant potential (TUMP). The rate of malignancy, including NIFTP and TUMP in this definition, was 80%, 42.8%, 13%, 10%, and 23% for nodules with a high suspicion, intermediate suspicion, low suspicion, very low suspicion, and undefined ultrasonographic pattern, respectively. Considering NIFPT and TUMP as benign, these rates were 72%, 22.4%, 4.3%, 0%, and 15.4%, respectively. The addition of Doppler analysis did not significantly improve the prediction of malignancy obtained with the ATA classification alone. The results of this prospective study show the usefulness of the ATA ultrasonographic classification for predicting malignancy specifically in thyroid nodules >1 cm with indeterminate cytology. The ATA category of the nodule should influence the decision for follow-up, molecular tests, or surgery. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 30081407     DOI: 10.1055/a-0655-3016

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

1.  Ultrasound characterization for thyroid nodules with indeterminate cytology: inter-observer agreement and impact of combining pattern-based and scoring-based classifications in risk stratification.

Authors:  Cesar A Lam; Melissa J McGettigan; Zachary J Thompson; Laila Khazai; Christine H Chung; Barbara A Centeno; Bryan McIver; Pablo Valderrabano
Journal:  Endocrine       Date:  2019-07-12       Impact factor: 3.633

2.  The analysis of differential diagnosis of benign and malignant thyroid nodules based on ultrasound reports.

Authors:  Shumei Miao; Mang Jing; Rongrong Sheng; Dai Cui; Shan Lu; Xin Zhang; Shenqi Jing; Xiaoliang Zhang; Tao Shan; Hongwei Shan; Tingyu Xu; Bing Wang; Zhongmin Wang; Yun Liu
Journal:  Gland Surg       Date:  2020-06

3.  Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer.

Authors:  Syed Z Ali; Allan Siperstein; Peter M Sadow; Allan C Golding; Giulia C Kennedy; Richard T Kloos; Paul W Ladenson
Journal:  Cancer Cytopathol       Date:  2019-04-24       Impact factor: 4.264

4.  Focal Thyroid Incidentalomas on 18F-FDG PET/CT: A Systematic Review and Meta-Analysis on Prevalence, Risk of Malignancy and Inconclusive Fine Needle Aspiration.

Authors:  J F de Leijer; M J H Metman; A van der Hoorn; A H Brouwers; S Kruijff; B M van Hemel; T P Links; H E Westerlaan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-20       Impact factor: 5.555

5.  Association of patient characteristics, ultrasound features, and molecular testing with malignancy risk in Bethesda III-V thyroid nodules.

Authors:  Guy Talmor; Ido Badash; Sheng Zhou; Yun Ji Kim; Niels C Kokot; Wayne Hsueh; Tamara Chambers
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-07-05

6.  ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.

Authors:  Thayse Lozovoy Madsen Barbosa; Cleo Otaviano Mesa Junior; Hans Graf; Teresa Cavalvanti; Marcus Adriano Trippia; Ricardo Torres da Silveira Ugino; Gabriel Lucca de Oliveira; Victor Hugo Granella; Gisah Amaral de Carvalho
Journal:  BMC Endocr Disord       Date:  2019-10-29       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.